Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-10-02
2008-09-30
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S277000
Reexamination Certificate
active
07429595
ABSTRACT:
The present invention is directed to acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4 -diaminocyclohexyl)-purines of the formulawhere Z is selected from the group consisting of —S(O)2—, and —C(O)—.
REFERENCES:
patent: 4232155 (1980-11-01), Naito et al.
patent: 6413974 (2002-07-01), Dumont et al.
patent: 6479487 (2002-11-01), Dumont et al.
patent: 6794390 (2004-09-01), Lum et al.
patent: 6861524 (2005-03-01), Borcherding et al.
patent: 7041824 (2006-05-01), Bordon-Pallier et al.
patent: 7122669 (2006-10-01), Haesslein
patent: 2002/0035252 (2002-03-01), Lum et al.
patent: 2003/0018038 (2003-01-01), Thompson et al.
patent: 2003/0092909 (2003-05-01), Trova
patent: 2003/0105098 (2003-06-01), Dumont et al.
patent: 2005/0187228 (2005-08-01), Haesslein
patent: 545413 (1993-06-01), None
patent: 0545413 (2000-07-01), None
patent: WO 94/17090 (1994-08-01), None
patent: WO 9417090 (1994-08-01), None
patent: WO 96/02543 (1996-02-01), None
patent: WO 9602543 (1996-02-01), None
patent: WO 97/16452 (1997-05-01), None
patent: WO 9716452 (1997-05-01), None
patent: WO 98/05335 (1998-02-01), None
patent: WO 9805335 (1998-02-01), None
patent: WO 99/07705 (1999-02-01), None
patent: WO 9907705 (1999-02-01), None
patent: WO 00/44750 (2000-08-01), None
patent: WO 0044750 (2000-08-01), None
Kath John C. Patent Focus: Inhibitors of Tumour Cell Growth, J.C., Oncologic, Endocrine & Metabolic, Exp. Opin. Ther. Patents (2000), 10(6):803-818.
Myers Michael R et al., Inhibitors of Tyrosine Kinases Involved in Inflammation and Autoimmune Disease, Current Pharmaceuticals Design, 1997, vol. 3, No. 5, pp. 473-502.
Park David S et al., G1/S Cell Cyclic Blockers and Inhibitors of Cyclin-Dependent Kinases Suppress Camptothecin-Induced Neuronal Apoptosis, J.
Park David S et al., Inhibitors of Cyclin-Dependent Kinases Promote Survival of post-mitotic Neuronally Differentiated PC12 Cells and Sympathetic Neurons, J. of Biological Chemistry, vol. 271, No. 14:8161-8169 (1996).
Janet R. Maurer, Lesson 23, vol. 14-Lymphangioleiomyomatosis <http://www.chestnet.org/education/online/pccu/vol14/lesson23.php> downloaded from the internet Mar. 5, 2003.
Peckham, ed., Oxford Textbook of Oncology vol. 1 (Oxford University Press, 1995), p. 452.
Kath John C, Patent Focus: Inhibitors of Tumour Cell Growth, J.C., Oncologic, Endocrine & Metabolic, Exp. Opin. Ther. Patents (2000), 10(6):803:818.
Myers Michael R et al., Inhibitors of Tyrosine Kinases Involved In Inflammation and Autoimmune Disease, Current Pharmaceuticals Design, 1997, vol. 3, No. 5, pp. 473-502.
Park David S et al., G1/S Cell Cycle Blockers and Inhibitors of Cyclin-Dependent Kinases Suppress Camptothecin-Induced Neuronal Apoptosis, J. of Neuroscience, 17(4):1256-1270 (1997).
Park David S et al., Inhibitors of Cyclin-Dependent Kinases Promote Survival of Post-mitotic Neuronally Differentiated PC12 Cells and Sympathetic Neurons, J. of Biological Chemistry, vol. 271, No. 14:8161-8169 (1996).
Rosania gustavo R et al., Targeting Hyperproliferative Disorders with Cyclin Dependent Kianse Inhibitors, Publication Exp. Opin. Ther. Patents (2000) 10(2):215-230.
Knockaert et al., Pharmacological inhibitors of cyclin-dependent kinases, Trends in Pharmacological Sciences, vol. 23, No. 9, Sep. 2002, pp. 417-425.
Sherr et al., CDK inhibitors: positive and negative regulators of G1-phase progression, Genes & Dev. 1999, vol. 13, pp. 1501-1512.
Borcherding David
Dumont Jennifer A.
Peet Norton P.
Wright Paul S.
Aventis Pharmaceuticals Inc.
Berch Mark L
LandOfFree
Acyl and sulfonyl derivatives of 6,9-disubstituted... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acyl and sulfonyl derivatives of 6,9-disubstituted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyl and sulfonyl derivatives of 6,9-disubstituted... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3991578